SLB Limited/NV's Executive Vice President and Chief Financial Officer Stéphane Biguet recorded a cash sale of company stock at the end of January 2026, according to disclosures filed with the Securities and Exchange Commission.
On January 26, 2026, Biguet sold 61,017 shares of SLB common stock at $49.70 per share, generating total proceeds of $3,032,544. The transaction appears in a Form 4 filing submitted to the SEC that documents the officer's recent equity activity.
That sale followed activity earlier in the week. On January 23, 2026, Biguet was issued 51,885 shares at no cash cost after meeting the performance conditions attached to performance share units originally granted on January 18, 2023. Also on January 23 he disposed of 20,418 shares at $50.25 per share to satisfy tax-withholding requirements on the vesting event, producing proceeds of $1,026,004.
After completing these transactions, the filing shows Biguet's direct ownership in SLB totals 155,548 shares.
These insider transactions come amid heightened analyst attention following SLB's fourth-quarter 2025 results. The company reported earnings that exceeded expectations, prompting a range of target-price revisions among brokerages.
- Stifel raised its price target to $56, citing solid earnings performance and the company's acquisition of ChampionX.
- Raymond James lifted its target to $57, pointing to particularly strong showings in SLB's Digital and Production Systems segments.
- BMO Capital increased its target to $55, noting results that outpaced both their internal forecasts and consensus estimates.
- In contrast, Freedom Capital Markets downgraded SLB from Hold to Sell, attributing the action to weak global drilling activity that weighed on earnings.
- JPMorgan raised its target to $54, citing expected international growth in markets such as Saudi Arabia and Mexico.
Taken together, the insider share activity and the recent slate of analyst moves illustrate a mix of internal compensation outcomes and external market views in the wake of SLB's quarterly performance. The Form 4 filing provides concrete detail on the timing, prices, and volumes of Biguet's transactions, while analyst revisions reflect differing interpretations of near-term demand and international growth prospects.
Where the filings and analyst notes intersect is in the narrow factual record: the grant and vesting of performance shares tied to 2023 criteria, the subsequent tax-driven disposition, the market sale that produced just over $3.03 million in proceeds, and the updated analyst price targets following the company's fourth-quarter 2025 results.